Our Company’s Background
Our technology was developed in Dr. John Fahy’s airway biology laboratory at the University of California San Francisco (UCSF) in collaboration with Dr. Stefan Oscarson’s glycochemistry laboratory at University College Dublin and Dr. Anne Marie Healy’s pharmaceutics laboratory at Trinity College Dublin. The efforts of this research consortium have led to over $18M in NIH funding, resulting in the identification of our lead therapeutic candidate (AER-01), establishment of preliminary safety and efficacy profiles, and the production of clinical trial API.
Aer Therapeutics Team
We are led by an experienced management team with an established track record of success in the development of drug-candidates.
Management Team
Irina Gitlin, PhD
Vice President, Research and Development
Blair Capel
Director of Finance
Rony Nasrallah
Associate Director, Technical Operations
Jordan Low
Director of Clinical Operations
Board of Directors
John Fahy MD MSc
Founder
Rishi Gupta, JD
Partner, OrbiMed
Thomas P. Mathers
Executive Chairman
Christy Shaffer, PhD
Partner, Hatteras Ventures
Tim Shannon, MD
Partner, Canaan Partners